Tianjin Chase Sun Pharmaceutical Co.,Ltd

SZSE:300026 Rapport sur les actions

Capitalisation boursière : CN¥10.2b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Tianjin Chase Sun PharmaceuticalLtd Gestion

Gestion contrôle des critères 3/4

Tianjin Chase Sun PharmaceuticalLtd's CEO is Dan Zheng, appointed in Mar 2017, has a tenure of 7.42 years. directly owns 0.05% of the company’s shares, worth CN¥5.03M. The average tenure of the management team and the board of directors is 7.4 years and 5 years respectively.

Informations clés

Dan Zheng

Directeur général

CN¥2.6m

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général7.4yrs
Propriété du PDG0.05%
Durée moyenne d'occupation des postes de direction7.4yrs
Durée moyenne du mandat des membres du conseil d'administration5yrs

Mises à jour récentes de la gestion

Recent updates

These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Jun 12
There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

May 22
Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

May 21
This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 04
Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

PDG

Dan Zheng (60 yo)

7.4yrs

Titularisation

CN¥2,608,700

Compensation

Ms. Dan Zheng serves as General Manager of Tianjin Chase Sun Pharmaceutical Co.,Ltd since March 24, 2017 and serves as its Vice Chairman since April 24, 2019. She serves as Director of Tianjin Chase Sun Ph...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Dan Zheng
GM & Vice Chairman7.4yrsCN¥2.61m0.050%
CN¥ 5.0m
Wu Jun Lan
Executive GM12.7yrsCN¥1.81m0.050%
CN¥ 5.0m
Wu Sun
Deputy GMno dataCN¥979.30kpas de données
Chun Xu Li
Deputy GMno dataCN¥1.11m0.022%
CN¥ 2.3m
Rui Qiang Chen
GM of Human Resource Center & Deputy GMno dataCN¥1.21m0.023%
CN¥ 2.3m
Kun Zhang
Deputy General Manager7.4yrsCN¥1.32m0.031%
CN¥ 3.1m
Xiao Zhong Lu
Deputy General Manager2.3yrsCN¥1.76mpas de données

7.4yrs

Durée moyenne de l'emploi

49yo

Âge moyen

Gestion expérimentée: 300026's management team is seasoned and experienced (7.4 years average tenure).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Dan Zheng
GM & Vice Chairman7.3yrsCN¥2.61m0.050%
CN¥ 5.0m
Wu Jun Lan
Executive GM5.3yrsCN¥1.81m0.050%
CN¥ 5.0m
Wu Sun
Deputy GM5.3yrsCN¥979.30kpas de données
Chun Xu Li
Deputy GMless than a yearCN¥1.11m0.022%
CN¥ 2.3m
Xiaoqing Yao
Chairman23.9yrsCN¥2.66m10.24%
CN¥ 1.0b
Peng Fei Tu
Independent Director4.6yrsCN¥120.00kpas de données
Dan Liang
Employee Representative Member of Supervisory Board & Securities Affairs Representative11.3yrsCN¥91.00kpas de données
Shengtian Wang
Independent Director6.7yrsCN¥120.00kpas de données
Tao Gong
Independent Director4.6yrsCN¥120.00kpas de données
Li Li
Independent Director3.8yrsCN¥120.00kpas de données
Sen Lin
Directorless than a yearpas de donnéespas de données
Juan Chen
Director1.1yrspas de donnéespas de données

5.0yrs

Durée moyenne de l'emploi

55yo

Âge moyen

Conseil d'administration expérimenté: 300026's board of directors are considered experienced (5 years average tenure).